High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells

Journal of Neuroscience

Volumn 18, Issue 9, 1998, Pages 3224-3232

  Lezoualc'h, Frank ^a   Sagara, Yutaka ^b   Holsboer, Florian ^a   Behl, Christian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Antioxidant enzymes; Glucocorticoids; Neuroprotection; NF B; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; DEXAMETHASONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSCRIPTION; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0032080328     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-09-03224.1998     Document Type: Article

References (55)

1. Aebi H (1974) Methods of enzymatic analysis. In: Catalase, Vol I (Bergmeyer H, ed), pp 673-684. New York: Catalase Academic.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
3. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-681.
4. Bäuerle P, Baltimore D (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
5. Bäuerle P, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
6. Beg AA, Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
7. Behl C (1997) Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease (review). Cell Tissue Res 296:471-480.
8. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
9. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101-106.
10. Buussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301.
11. Braak H, Braak E (1991) Neuroputhologicul staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
12. Brockman JA, Scherer DC, Mckinsey TA, Hall SM, Qi XX, Lee WY, Ballard DW (1995) Coupling of a signal response domain in IkBa to multiple pathways for NF-κB activation. Mol Cell Biol 15:2809-2818.
13. Brugg B, Michel PP, Agid Y, Ruberg M Ceramide (1996) Ceramide induces apoptosis in cultured mesencephulic neurons. J Neurochem 66:733-739.
14. Caldenhoven E, Liden J, Wissink S, Vandestolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Vandersaag PT (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412.
15. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
16. De Bosscher K, Schmitz ML, Berghe WV, Plaisance S, Fiefs W, Haegeman G (1997) Glucocorticoid-mediated repression of nuelear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 94:13504-13509.
17. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
18. Grilli M, Chiu JS, Lenardo M (1993) NF-κB and Rel: participation in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62.
19. Grilli M, Ribola M, Alberici A, Valerio A, Memo M, Spano P (1995) Identification and characterization of a κB/Rel binding site in the regulatory region of the APP gene. J Biol Chem 270:26774-26777.
20. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274:1383-1385.
21. Gunzler W, Flohe L (1985) Glutathione peroxidase. In: Handbook of methods for oxygen radical research (Greenwald R, ed), pp 285-290. Boca Raton, FL: CRC.
22. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine. Oxford: Oxford UP.
23. Heck S, Bender K, Kulimann M, Göttlicher M, Herrlich P, Cato ACB (1997) IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 16:4698-4707.
24. Israel A (1995) A role for phosphorylation and degradation in the control of NF-κB activity. Trends Genet 11:203-205.
25. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NF-κB-B is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 94:2642-2647.
26. Kretz-Remy C, Mehlen P, Mirault ME, Arrigo AP (1996) Inhibition of IκB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J Cell Biol 133:1083-1093.
27. Liu Z, Hsu H, Goeddel DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
28. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radie Biol Med 23:134-147.
29. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
30. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel R (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10:243-254.
31. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:2005-2015.
32. Miyamoto S, Chiao PJ, Verma IM (1994) Enhanced IκBa degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol Cell Biol 14:3276-3282.
33. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystinc transport leading to oxidative stress. Neuron 2:1547-1558.
34. Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
35. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P (1992) Complement activation by β-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89:10016-10020.
36. Sagara Y, Dargusch R, Klier FG, Schubert D, Behl C (1996) Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J Neurosci 16:497-505.
37. Sapolsky RM (1987) Glucocorticoids and hippocampal damagft. Trends Neurosci 10:346-349.
38. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS (1995) Role of transcriptional activation of IκB in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
39. Schmidt KN, Amstad P, Cerutti P, Bäuerle PA (1995) The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol 2:13-22.
40. Schreck R, Zorbas H, Winnacker EL, Bäuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10:2247-2258.
41. Schreiber E, Matthias P, Müller M, Schaffner W (1989) Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 17:6419.
42. Schubert D, Behl C (1993) The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 629:275-282.
43. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-706.
44. Siman R, Card JP, Nelson RB, Davis LG (1989) Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3:275-285.
45. Smith MA, Syre LM, Monnier VM, Perry G (1995) Radical ageing in Alzheimer's disease. Trends Neurosci 18:172-176.
46. Taglialatela G, Robinson R, Perezpolo JR (1997) Inhibition of NF-κB activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 47:155-162.
47. Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502-522.
48. Unlap MT, Jope RS (1997) Dexamethasone attenuates NF-κB DNA binding activity without inducing IκB levels in rat brain in vivo. Mol Brain Res 45:83-89.
49. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-α-induced apoptosis. Science 274:787-789.
50. Van der Burg B, Liden J, Okret S, Delaunay F, Wissink S, van der Saag P, Gustafsson J-A (1997) Nuclear factor-κ B repression in antiinflammation and immunosuppression by glucocorticoids. Trends Endocrinol Metab 8:152-157.
51. Verma I, Stevenson J, Schwarz EM, Van Antwerp D, Miyammo S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
52. Wang CY, Many MW, Baldwin Jr AS (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of apoptosis. Science 274:784-787.
53. Wu M. Lee HY, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH, Sonenshein GE (1996) Inhibition of NF-κB/rel induces apoptosis of murine B cells. EMBO J 15:4682-4690.
54. Yao H, Labudda K, Rim C, Capodieci P, Loda M, Stork PJ (1995a) Cyclic adenosine monophosphate can convert epidermal growth factor into a differentiating factor in neuronal cells. J Biol Chem 270:20748-20753.
55. Yao KS, Godwin AK, Johnson SW, Ozols RF, Odwyer PJ, Hamilton TC (1995b) Evidence for altered regulation of gamma-glutamylcysteine synthctase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res 55:4367-4374.